Hipower Energy Spolka Akcyjna Logo

Hipower Energy Spolka Akcyjna

Develops and commercializes hydrogen-based solutions and fuel cell technology.

HPE | WAR

Overview

Corporate Details

ISIN(s):
PLCRBON00018 (+3 more)
LEI:
259400K207QFVSVSA489
Country:
Poland
Address:
WARSZAWA MARSZAŁKOWSKA 111, 00-102 WARSZAWA

Description

Hipower Energy Spolka Akcyjna is a clean energy company that creates, develops, and commercializes innovative hydrogen-based solutions. The company's primary focus is on hydrogen and fuel cell technology. Key offerings include a proprietary hydrogen recycling and purification technology for industrial exhaust gases, methanol fuel cells, and comprehensive mobile charging stations for electric vehicles. The company is dedicated to advancing green energy through research and development in hydrogen applications.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-16 11:15
zal01_VK_1512_FormularzA.pdf
Polish 79.1 KB
2025-12-16 11:15
Zawiadomienie w trybie art. 69 ustawy o ofercie o zmianie udziału w ogólnej lic…
Polish 646 bytes
2025-12-12 16:16
zal01_MK_1212_FormularzA.pdf
Polish 75.8 KB
2025-12-12 16:16
Zawiadomienie w trybie art. 69 ustawy o ofercie o zmianie udziału w ogólnej lic…
Polish 646 bytes
2024-05-07 07:53
THE ISSUER HAS ENTRED ENTRED INTO A TERM SHEET AGREEMENT - Content (PL)
English 1.3 KB
2024-05-07 07:43
ZAWARCIE UMOWY TERM SHEET PRZEZ EMITENTA - Content (PL)
Polish 1.7 KB
2024-04-09 09:56
ZAWARCIE UMOWY PRZEZ PODMIOT POWIĄZANY - Content (PL)
Polish 1.2 KB
2024-03-18 18:32
zal01_Zawiadomienie4AgioFunds.pdf
Polish 77.5 KB
2024-03-18 18:32
Zmiana udziałów w głosach na Walnym Zgromadzeniu Akcjonariuszy Emitenta - Conte…
Polish 234 bytes
2024-03-18 18:25
zal01_Zawiadomienie3PCB.pdf
Polish 48.4 KB
2024-03-18 18:25
Zmiana udziałow w głosach na Walnym Zgromadzeniu Emitenta - Content (PL)
Polish 233 bytes
2024-03-18 18:14
zal01_Zawiadomienie2FRFinance.pdf
Polish 48.7 KB
2024-03-18 18:14
Zmiana udziałów w głosach na Walnym Zgromadzeniu Akcjonariuszy Emitenta - Conte…
Polish 235 bytes
2024-03-18 18:05
zal01_Zawiadomienie1Ecommerce.pdf
Polish 48.3 KB
2024-03-18 18:05
Zmiana udziałow w głosach na Walnym Zgromadzeniu Akcjonariuszy - Content (PL)
Polish 233 bytes

Automate Your Workflow. Get a real-time feed of all Hipower Energy Spolka Akcyjna filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Hipower Energy Spolka Akcyjna

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Hipower Energy Spolka Akcyjna via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.